Risk factors for progression of and treatment options for NAFLD in children
Phillipp Hartmann, Bernd Schnabl – 31 January 2018
Phillipp Hartmann, Bernd Schnabl – 31 January 2018
Phillipp Hartmann, Bernd Schnabl – 31 January 2018
Alex Frydrychowicz – 31 January 2018
Abigail Mills, Vincent Mellnick – 31 January 2018
Tamir Diamond, Nadia Ovchinsky – 31 January 2018
Ezequiel Mauro, Gonzalo Crespo, Carla Montironi, Maria‐Carlota Londoño, Alba Díaz, Xavier Forns, Miquel Navasa – 31 January 2018
Adrien Guillot, Imène Gasmi, Arthur Brouillet, Yeni Ait‐Ahmed, Julien Calderaro, Isaac Ruiz, Bin Gao, Sophie Lotersztajn, Jean‐Michel Pawlotsky, Fouad Lafdil – 30 January 2018 – Liver progenitor cells (LPCs)/ductular reactions (DRs) are associated with inflammation and implicated in the pathogenesis of chronic liver diseases. However, how inflammation regulates LPCs/DRs remains largely unknown. Identification of inflammatory processes that involve LPC activation and expansion represent a key step in understanding the pathogenesis of liver diseases.
Wenchen Pu, Jiao Li, Yuanyuan Zheng, Xianyan Shen, Xin Fan, Jian‐Kang Zhou, Juan He, Yulan Deng, Xuesha Liu, Chun Wang, Shengyong Yang, Qiang Chen, Lunxu Liu, Guolin Zhang, Yu‐Quan Wei, Yong Peng – 30 January 2018 – Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, but there are few effective treatments. Aberrant microRNA (miRNA) biogenesis is correlated with HCC development. We previously demonstrated that peptidyl‐prolyl cis‐trans isomerase NIMA‐interacting 1 (Pin1) participates in miRNA biogenesis and is a potential HCC treatment target.
Jun Gong, Chun Fang, Peng Zhang, Pi‐Xiao Wang, Yixing Qiu, Li‐Jun Shen, Li Zhang, Xue‐Yong Zhu, Song Tian, Feng Li, Zhihua Wang, Zan Huang, Aibing Wang, Xiao‐Dong Zhang, Zhi‐Gang She – 30 January 2018 – Tumor progression locus 2 (TPL2), a serine/threonine kinase, has been regarded as a potentially interesting target for the treatment of various diseases with an inflammatory component. However, the function of TPL2 in regulating hepatocyte metabolism and liver inflammation during the progression of nonalcoholic fatty liver disease (NAFLD) is poorly understood.
Pietro Lampertico, Thomas Berg – 30 January 2018